190,546 Shares in Core Laboratories Inc. (NYSE:CLB) Acquired by Eagle Asset Management Inc.

Eagle Asset Management Inc. purchased a new position in shares of Core Laboratories Inc. (NYSE:CLB) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 190,546 shares of the oil and gas company’s stock, valued at approximately $3,531,000. Eagle Asset Management Inc. owned 0.41% of Core Laboratories at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in the business. Headlands Technologies LLC purchased a new position in shares of Core Laboratories in the 2nd quarter valued at about $36,000. nVerses Capital LLC acquired a new stake in shares of Core Laboratories in the 3rd quarter valued at $48,000. GAMMA Investing LLC lifted its position in shares of Core Laboratories by 23.9% during the 2nd quarter. GAMMA Investing LLC now owns 4,425 shares of the oil and gas company’s stock worth $90,000 after purchasing an additional 855 shares during the last quarter. Northwestern Mutual Wealth Management Co. grew its stake in shares of Core Laboratories by 11.9% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 5,636 shares of the oil and gas company’s stock worth $114,000 after purchasing an additional 600 shares in the last quarter. Finally, Signaturefd LLC increased its holdings in Core Laboratories by 12.8% in the second quarter. Signaturefd LLC now owns 6,776 shares of the oil and gas company’s stock valued at $137,000 after buying an additional 767 shares during the last quarter. 97.81% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have recently issued reports on CLB. StockNews.com raised Core Laboratories from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Citigroup dropped their price target on shares of Core Laboratories from $15.00 to $14.00 and set a “sell” rating on the stock in a research note on Thursday, October 31st. Two research analysts have rated the stock with a sell rating and three have issued a hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $17.00.

Core Laboratories Price Performance

Shares of NYSE CLB opened at $20.84 on Tuesday. The stock has a market cap of $978.44 million, a P/E ratio of 32.06, a P/E/G ratio of 1.43 and a beta of 2.35. Core Laboratories Inc. has a twelve month low of $13.82 and a twelve month high of $25.13. The stock has a 50 day moving average of $19.33 and a two-hundred day moving average of $19.49. The company has a current ratio of 2.48, a quick ratio of 1.79 and a debt-to-equity ratio of 0.55.

Core Laboratories (NYSE:CLB) last issued its quarterly earnings data on Wednesday, October 23rd. The oil and gas company reported $0.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.21 by $0.04. Core Laboratories had a net margin of 5.83% and a return on equity of 15.84%. The company had revenue of $134.40 million for the quarter, compared to the consensus estimate of $134.16 million. During the same period last year, the firm posted $0.22 EPS. Core Laboratories’s revenue for the quarter was up 7.2% on a year-over-year basis. On average, research analysts forecast that Core Laboratories Inc. will post 0.8 earnings per share for the current year.

Core Laboratories Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, November 25th. Shareholders of record on Monday, November 4th were paid a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a yield of 0.19%. The ex-dividend date of this dividend was Monday, November 4th. Core Laboratories’s dividend payout ratio is presently 6.15%.

Core Laboratories Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.